Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Better Therapeutics Inc (NQ: BTTX )

1.280 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.280
Bid (Size) 0.6568 (4)
Ask (Size) 1.700 (1)
Prev. Close 1.280
Today's Range 1.280 - 1.280
52wk Range 0.9120 - 5.100
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Better Therapeutics Posts Encouraging Data Establishing Proof-Of-Concept For Prescription Digital Therapy Platform
 
Via Benzinga
Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results
From Better Therapeutics, Inc.
Via Business Wire

Performance

YTD
+16.36%
+16.36%
1 Month
-1.54%
-1.54%
3 Month
-8.57%
-8.57%
6 Month
-28.89%
-28.89%
1 Year
-65.68%
-65.68%

More News

Read More
Better Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics to Participate in BTIG Digital Health Forum
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Seeks FDA Approval For First Digital Therapeutic For Type 2 Diabetes
Via Benzinga
PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday
Via Benzinga
Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics to Release Third Quarter 2022 Financial Results and Provide Business Update on November 14, 2022
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Appoints Diane Gomez-Thinnes as Chief Commercial Officer
From Better Therapeutics, Inc.
Via Business Wire
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
Via InvestorPlace
Positive Results from Pivotal Trial of Better Therapeutics’ Investigational BT-001 Prescription Digital Therapy for Type 2 Diabetes Published in Diabetes Care
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Submits De Novo Request to U.S. FDA for BT-001 Investigational Prescription Digital Therapy for Type 2 Diabetes
From Better Therapeutics, Inc.
Via Business Wire
Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
Via Benzinga
Bridgeline Digital And 2 Other Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Better Therapeutics to Participate in Three Upcoming Investor Conferences
From Better Therapeutics
Via Business Wire
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket
Via Benzinga
Better Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics to Release Second Quarter 2022 Financial Results and Provide Business Update on August 11, 2022
From Better Therapeutics, Inc.
Via Business Wire
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
Via Benzinga
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.